PubMedCrossRef 7. Shimono N, Morici L, Casali N, Cantrell S, Sidders B, et al.: Hypervirulent mutant selleck compound of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A 2003, 100:15918–15923.PubMedCrossRef 8. Gioffre A, Infante E, Aguilar D, Santangelo MP, Klepp L, et al.: Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect 2005, 7:325–334.PubMedCrossRef 9. Marjanovic O, Miyata T, Goodridge A, Ku-0059436 cost Kendall LV, Riley LW: Mce2 operon mutant strain of Mycobacterium tuberculosis is attenuated in C57BL/6 mice. Tuberculosis (Edinb) 2010, 90:50–56.CrossRef 10. Santangelo
Mde L, Blanco F, Campos E, Soria M, Bianco MV, et al.: Mce2R from Mycobacterium tuberculosis represses the expression of the mce2 operon. Tuberculosis
(Edinb) 2009, 89:22–28.CrossRef 11. Rohde K, Yates RM, Purdy GE, Russell DG: Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007, 219:37–54.PubMedCrossRef 12. Santangelo MP, Blanco FC, Bianco MV, Klepp LI, Zabal O, et al.: Study of the role of Mce3R on the transcription of mce genes of Mycobacterium tuberculosis. BMC Microbiol 2008, 8:38.PubMedCrossRef 13. de la Paz SM, Klepp L, Nunez-Garcia J, Blanco FC, Soria M, et al.: Mce3R, a TetR-type transcriptional repressor, controls the expression of a regulon involved in lipid metabolism in Mycobacterium tuberculosis. Microbiology 2009, 155:2245–2255.CrossRef 14. Ferrer NL, Gomez AB, Neyrolles O, Gicquel B, Martin C: Interactions of attenuated Mycobacterium tuberculosis phoP Phospholipase D1 mutant with human macrophages. PLoS One 2010, 5:e12978.PubMedCrossRef 15. Katti MK, selleckchem Dai G, Armitige LY, Rivera Marrero C, Daniel S, et al.: The Delta fbpA mutant
derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells. Cell Microbiol 2008, 10:1286–1303.PubMedCrossRef 16. Marjanovic O, Iavarone AT, Riley LW: Sulfolipid accumulation in Mycobacterium tuberculosis disrupted in the mce2 operon. J Microbiol 2011, 49:441–447.PubMedCrossRef 17. Rivera-Marrero CA, Ritzenthaler JD, Newburn SA, Roman J, Cummings RD: Molecular cloning and expression of a novel glycolipid sulfotransferase in Mycobacterium tuberculosis. Microbiology 2002, 148:783–792.PubMed 18. Bardarov S, Bardarov S Jr, Pavelka MS Jr, Sambandamurthy V Jr, Larsen M, et al.: Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 2002, 148:3007–3017.PubMed 19. Blanco FC, Nunez-Garcia J, Garcia-Pelayo C, Soria M, Bianco MV, et al.: Differential transcriptome profiles of attenuated and hypervirulent strains of Mycobacterium bovis. Microbes Infect 2009, 11:956–963.PubMedCrossRef 20.